Document is current
Any future updates will be listed below
-
Authors
Rodriguez, Maeva
Ragot, Stéphanie
Coudroy, Rémi
Quenot, Jean-Pierre
Vignon, Philippe
Forel, Jean-Marie
Demoule, Alexandre
Mira, Jean-Paul
Ricard, Jean-Damien
Nseir, Saad
Colin, Gwenhael
Pons, Bertrand
Danin, Pierre-Eric
Devaquet, Jérome
Prat, Gwenael
Merdji, Hamid
Petitpas, Franck
Vivier, Emmanuel
Mekontso-Dessap, Armand
Nay, Mai-Anh
Asfar, Pierre
Dellamonica, Jean
Argaud, Laurent
Ehrmann, Stephan
Fartoukh, Muriel
Girault, Christophe
Robert, René
Thille, Arnaud W.
Frat, Jean-Pierre https://orcid.org/0000-0002-9176-7797
,
Chatellier, Delphine
Boissier, Florence
Veinstein, Anne
Robert, René
Dahyot-Fizelier, Claire
Dargent, Auguste
Large, Audrey
Begot, Emmanuelle
Mancia, Claire
Decavele, Maxence
Dres, Martin
Lehingue, Samuel
Papazian, Laurent
Paul, Marine
Marin, Nathalie
Le Meur, Matthieu
Laissy, Mohammed
Rouzé, Anahita
Henry-Lagarrigue, Matthieu
Yehia, Aihem
Martino, Frédéric
Cerf, Charles
Bailly, Pierre
Helms, Julie
Putegnat, Jean Baptiste
Razazi, Keyvan
Boulain, Thierry
Asfar, Pierre
Cabasson, Séverin
Wallet, Florent
Klouche, Kada
Bellec, Frédéric
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02668458 at ClinicalTrials.govDocuments that mention this clinical trial
Preoxygenation with non-invasive ventilation versus high-flow nasal cannula oxygen therapy for intubation of patients with acute hypoxaemic respiratory failure in ICU: the prospective randomised controlled FLORALI-2 study protocol (Pre-results)
https://doi.org/10.1136/bmjopen-2017-018611
Noninvasive ventilation vs. high-flow nasal cannula oxygen for preoxygenation before intubation in patients with obesity: a post hoc analysis of a randomized controlled trial
https://doi.org/10.1186/s13613-021-00892-8
-
Funding
Funding for this research was provided by:
Ministère de l’Enseignement Supérieur, de la Recherche Scientifique et des Technologies de l'Information et de la Communication (ID-RCB 2015-A00530-49)
- License Information
-
More Information
Article History
Received: 3 May 2021
Accepted: 21 June 2021
First Online: 22 July 2021
Declarations
:
: The study original trial was approved by the independent ethics committee of Poitiers (CPP Ouest III, number number2015-A00530) and registered at (NCT02668458).According to French law, this secondary analysis of the original study did not need ethics approval.
: JPF reports grants, personal fees and non-financial support from the “Fisher & Paykel HealthCare” firm, during the conduct of the original study; personal fees and non-financial support from SOS oxygène, outside the submitted work.AD reports personal fees from Medtronic, grants, personal fees and non-financial support from Philips, personal fees from Baxter, personal fees from Hamilton, personal fees and non-financial support from Fisher & Paykel, grants from French Ministry of Health, personal fees from Getinge, grants and personal fees from Respinor, grants and non-financial support from Lungpacer, outside the submitted work.CG reports non-financial support and other from Fisher & Paykel Healthcare, during the conduct of the study; personal fees from Fisher & Paykel Healthcare, outside the submitted work.JDR reports coverage by Fisher & Paykel Healthcare of expenses to attend scientific meetings.RC reports non-financial support from MSD, outside the submitted work.RR reports non-financial support from Fresenius Medical Care, from Baxter Gambro, outside the submitted work.AWT reports personal fees and non-financial support from Fisher & Paykel.SE reports personal consulting fees, speaker fees and research support from Aerogen Ltd and speaker fees and research support from Fisher & Paykel.The other authors declared no conflicts of interest.
